Pharvaris (PHVS) accounting officer sells 2,670 common shares on market

Rhea-AI Filing Summary

Pharvaris N.V. principal accounting officer Anna Nijdam sold 2,670 shares of common stock in an open-market transaction on June 4, 2026, at a weighted average price of about $30.87 per share. The shares sold were acquired upon vesting of restricted stock units, and she continues to hold 46,275 shares directly after the sale.

Insider Trade Summary

Net Seller: 2,670 shares ($82,425)

Net Sell 1 txn

Insider Nijdam Anna

Role Principal Accounting Officer

Sold 2,670 shs ($82K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,670	$30.8708	$82K

Holdings After Transaction: Common Stock — 46,275 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,670 shares Weighted average sale price: $30.8708 per share Sale price range: $30.68–$31.30 per share +2 more

5 metrics

Shares sold 2,670 shares Open-market sale of Pharvaris common stock on June 4, 2026

Weighted average sale price $30.8708 per share Average price across multiple trades in the June 4, 2026 sale

Sale price range $30.68–$31.30 per share Range of prices for individual trades included in the sale

Shares held after transaction 46,275 shares Direct Pharvaris common stock holdings following the sale

Transaction code S Sale in open market or private transaction, non-derivative

Key Terms

restricted stock units, weighted average sale price, open-market sale

3 terms

restricted stock units financial

"The shares sold were acquired upon vesting of restricted stock units on various dates."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average sale price financial

"The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.68 to $31.30 per share."

open-market sale financial

"transaction_action: "open-market sale" for the common stock transaction on June 4, 2026."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nijdam Anna

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		S		2,670	D	$30.8708(1)	46,275	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.68 to $31.30 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	/s/ Marnus Nel, Attorney-in-Fact for Anna Nijdam	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Pharvaris (PHVS) officer Anna Nijdam report?

Anna Nijdam reported selling 2,670 Pharvaris common shares in an open-market transaction. The sale occurred on June 4, 2026, and involved stock previously acquired through vesting of restricted stock units on various dates, according to the disclosure and accompanying explanatory footnote.

At what price did Anna Nijdam sell Pharvaris (PHVS) shares?

She sold the 2,670 Pharvaris shares at a weighted average price of $30.8708 per share. The filing notes multiple trades, with individual prices ranging from $30.68 to $31.30 per share, all aggregated into the reported weighted average sale price figure.

How many Pharvaris (PHVS) shares does Anna Nijdam hold after the sale?

Following the reported sale, Anna Nijdam directly holds 46,275 Pharvaris common shares. This post-transaction holding figure comes from the Form 4 and reflects her remaining direct ownership stake after disposing of 2,670 shares in the June 4, 2026 open-market transaction.

Were Anna Nijdam’s Pharvaris (PHVS) share sales linked to RSU vesting?

Yes. The filing explains that the 2,670 Pharvaris shares sold were originally acquired upon vesting of restricted stock units on various dates. This means the sale involved shares received as equity compensation rather than a long-standing open-market investment position.

What type of transaction did Pharvaris (PHVS) report for Anna Nijdam?

The transaction is classified as an open-market sale of common stock. The Form 4 uses transaction code “S,” described as a sale in an open market or private transaction, and identifies the security as Pharvaris N.V. common stock held directly by Anna Nijdam.